Amedisys (AMED) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Amedisys Reports Fourth Quarter and Year End 2020 Financial Results
February 24, 2021 4:05 PM ESTBATON ROUGE, La., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2020.
Three-Month Periods Ended December 31, 2020 and 2019
Net service revenue increased $50.0Â million to $550.7Â million compared to $500.7Â million in 2019.Net income attributable to Amedisys, Inc. of $45.2Â million compared to $27.7Â million in 2019.Net income attributable to Amedisys, Inc. per diluted share of $1.36 compared to $0.83 in 2019.Adjusted Quarterly Results*
Adjusted EBITDA of $78.1Â million compared to $52.2Â million in 2019.Adjusted net service revenue of $550.7Â million compared to $500.7Â million in... More